GAO: FDA fails to follow up on unproven drugs
Sunday, October 25, 2009 - 23:42
in Health & Medicine
WASHINGTON (AP) -- The Food and Drug Administration has allowed drugs for cancer and other diseases to stay on the market even when follow-up studies showed they didn't extend patients' lives, say congressional investigators....
Read the whole article on AP Health
More from AP Health
Related
- Project Zero Delay accelerates drug's path to clinical trialMon, 3 Aug 2009, 16:24:58 EDT
- ICT fails to accelerate drug approvalsThu, 19 Nov 2009, 9:58:09 EST
- Anti-inflammatory drugs may defeat a treatment-resistant type of cancerWed, 24 Jun 2009, 16:39:03 EDT
- FDA approved leukemia drugs shows promise in ovarian cancer cellsTue, 10 Nov 2009, 9:09:38 EST
- Post-marketing studies finding adverse events in drugs used in childrenTue, 2 Sep 2008, 11:23:39 EDT